Physician profile
Marc A Camacho
NPI 1114188455
$3,123.02
in general payments reported to CMS, 2019-2025
19 companies · $57.82 in 2025
The $57.82 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,503 · 2020: $486 · 2021: $46.93 · 2022: $992 · 2023: $23.37 · 2024: $13.89 · 2025: $57.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $95.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $95.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $991.79 | 2022-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| W. L. Gore & Associates, INC. | $536.34 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Boston Scientific Corporation | $271.18 | 2019-2021 | |
| Medtronic Vascular, INC. | $252.84 | 2019-2020 | |
| Cook Medical LLC | $182.30 | 2019 | |
| Janssen Pharmaceuticals, INC | $168.97 | 2019-2020 | |
| Getinge USA Sales, LLC | $166.06 | 2019 | |
| Cardinal Health 200 LLC | $105.57 | 2020 | |
| Livanova USA, INC. | $98.76 | 2020 | |
| Bard Peripheral Vascular, INC. | $76.78 | 2019-2020 | |
| Smith+Nephew, INC. | $60.87 | 2019-2022 | |
| Misonix INC | $47.73 | 2019 | |
| Terumo Medical Corporation | $46.53 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.16 | 2019-2020 | |
| Cardiovascular Systems INC. | $21.15 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Normatec Industries, LP | $15.96 | 2019 | |
| Teleflex LLC | $15.21 | 2019 | |
| Pfizer INC. | $14.93 | 2019 | |
| Ossur Americas, INC. | $13.89 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Camacho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.